Advantage Multi^TM for Dogs (imidacloprid + moxidectin)
Topical Solution

Advantage Multi for Dogs combines 100 percent prevention for heartworm disease, as shown in clinical trials, with the flea control of Advantage^®, and the treatment and control of intestinal worms (hookworms, roundworms and whipworms) - all in one, convenient, monthly topical solution.

Key Benefits¹:

• 100 percent effective at preventing heartworm disease caused by Dirofilaria immitis, as shown in clinical trials.
• 100 percent effective treatment and control of hookworm infections caused by Ancylostoma caninum and Uncinaria stenocephala (adults, immature adults and fourth stage larvae).
• Up to 98.2 percent effective treatment and control of roundworm infections caused by Toxocara canis (adults and fourth stage larvae).
• Up to 100 percent effective for the treatment and control roundworm infection caused by Toxascaris leonina (adults).
• Up to 98.6 percent effective treatment and control of whipworm infections caused by Trichuris vulpis (adults).
• Safe and effective, when used topically as directed, for dogs and puppies that are at least seven weeks of age and that weigh at least three pounds.

Important Safety Information

Like all topical animal health treatments, Advantage Multi for Dogs, is not to be given to dogs orally, is not for human use, and should be kept out of the reach of children. Ingestion of this product by dogs may cause serious adverse reactions including depression, salivation, dilated pupils, incoordination, panting and generalized muscle tremors. In avermectin-sensitive dogs, the signs may be more severe and may include coma and death. Reduce the risk of accidental oral ingestion by separating treated pets for 30 minutes. (see indications and warnings.) Children should not come in contact with the application sites for two hours after application. Ask your veterinarian if this product is right for your dog.

[1] Freedom of Information Summary, NADA 141-251, Advantage Multi for Dogs, Bayer HealthCare LLC, 06/28/2006.